Risk of Cardiorespiratory Mortality Associated with Emissions from a Cement Plant: A Residential Cohort Study
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Design
2.1.1. Study Domain
2.1.2. Definition of the Cohort and the Follow-Up Period
2.2. Exposure Assessment
2.2.1. The Study Plant
2.2.2. Dispersion Modeling System
2.2.3. Population Exposure to Cement Plant
- Class 1 (reference; least exposed class): 0.068–0.198 μg/m3;
- Class 2: 0.199–0.291 μg/m3;
- Class 3: 0.292–0.369 μg/m3;
- Class 4 (class with higher exposure): 0.370–1.919 μg/m3.

2.2.4. Individual Exposure to Confounding Factors Such as Intensive Vehicular Traffic and Socioeconomic Status
2.3. Health Outcomes
2.4. Statistical Analysis
- age group (0–44; 45–54; …; 85+). included as a categorical time-varying covariate to account for the strong age-related gradient in mortality. This ensures that differences in age distribution across exposure classes do not influence the estimated HRs;
- proximity to the principal road, used as a proxy for additional traffic-related air pollution, which could confound the association between plant-related NOx exposure and mortality (see Section 2.2.4);
- DI, representing socioeconomic status at the area level, a known predictor of health outcomes and potentially correlated with residential exposure (see Section 2.2.4).
3. Results
3.1. Descriptive Analyses
3.2. Mortality Analyses
- If the cases are less than three, then the HR is not reported for privacy and accuracy reasons.
- Comments are always made with reference to class 1.
- In addition to reporting the statistically significant results (1 − p > 0.95), are also reported those results that may indicate issues requiring further investigations, using (1 − p) as defined, thus considering worth of interest event those risks with a lower (1 − p) value. Moreover, since the cohort is not so large, the estimated risks could be more imprecise, so it is useful to also highlight risk signals with a significance > 80%. This indication is in line with what is suggested by the literature for going beyond the concept of statistical significance [38]. Therefore, it was decided to comment on risk associations with 1 − p > 0.80.
- Excess risks are reported as percentages.
- For all causes, Schoenfeld’s test allowed us to accept the hypothesis of proportional hazards (p > 0.05).
3.3. Sensitivity Analyses of the Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| NOx | Nitrogen Oxides |
| SO2 | Sulfur Dioxide |
| PY | Person-Years |
| WRF | Weather Research and Forecasting |
| DI | Deprivation Index |
| ICD-10 | International Classification of Diseases 10th Revision |
| HR | Hazard Ratio |
| 95%CI | Confidence Interval at 95% of Probability |
Appendix A
| Cause (ICD-10 Code) | Exposure Class | MEN | WOMEN | ||||||
|---|---|---|---|---|---|---|---|---|---|
| n | HR | 1 − p | CI95% | N | HR | 1 − p | CI95% | ||
| Natural causes (A00-R99) | 1 (ref.) | 332 | 1.00 | 364 | 1.00 | ||||
| 2 | 374 | 1.08 | 0.649 | 0.92–1.26 | 368 | 0.96 | 0.41 | 0.82–1.12 | |
| 3 | 193 | 1.09 | 0.669 | 0.91–1.31 | 197 | 1.11 | 0.771 | 0.93–1.33 | |
| 4 | 258 | 1.14 | 0.85 | 0.95–1.36 | 225 | 0.87 | 0.876 | 0.73–1.04 | |
| 5 | 185 | 1.20 | 0.943 | 0.99–1.44 | 212 | 1.19 | 0.95 | 1.00–1.42 | |
| Diseases of the circulatory system (I00-I99) | 1 (ref.) | 140 | 1.00 | 197 | 1.00 | ||||
| 2 | 156 | 1.08 | 0.497 | 0.85–1.38 | 181 | 0.89 | 0.726 | 0.72–1.10 | |
| 3 | 79 | 1.07 | 0.381 | 0.81–1.42 | 111 | 1.20 | 0.878 | 0.95–1.52 | |
| 4 | 99 | 1.08 | 0.429 | 0.82–1.43 | 118 | 0.86 | 0.766 | 0.67–1.10 | |
| 5 | 102 | 1.64 | 1 | 1.26–2.13 | 119 | 1.18 | 0.83 | 0.93–1.49 | |
| Heart diseases (I00-I52) | 1 (ref.) | 86 | 1.00 | 114 | 1.00 | ||||
| 2 | 100 | 1.11 | 0.511 | 0.82–1.5 | 119 | 1.05 | 0.252 | 0.80–1.37 | |
| 3 | 57 | 1.23 | 0.775 | 0.88–1.73 | 64 | 1.20 | 0.746 | 0.88–1.63 | |
| 4 | 65 | 1.09 | 0.364 | 0.77–1.54 | 77 | 0.93 | 0.374 | 0.68–1.26 | |
| 5 | 66 | 1.71 | 0.998 | 1.23–2.37 | 77 | 1.29 | 0.902 | 0.95–1.74 | |
| Ischemic heart diseases (IHD) (I20-I25) | 1 (ref.) | 28 | 1.00 | 26 | 1.00 | ||||
| 2 | 27 | 0.88 | 0.353 | 0.51–1.53 | 31 | 1.20 | 0.487 | 0.69–2.07 | |
| 3 | 14 | 0.91 | 0.227 | 0.47–1.74 | 16 | 1.35 | 0.643 | 0.71–2.54 | |
| 4 | 22 | 1.09 | 0.225 | 0.60–2.00 | 23 | 1.21 | 0.458 | 0.66–2.24 | |
| 5 | 20 | 1.55 | 0.854 | 0.86–2.80 | 18 | 1.09 | 0.205 | 0.58–2.03 | |
| Acute myocardial infarction (AMI) (I21) | 1 (ref.) | 12 | 1.00 | 11 | 1.00 | ||||
| 2 | 9 | 0.69 | 0.574 | 0.28–1.71 | 13 | 1.00 | 0.001 | 0.43–2.32 | |
| 3 | 4 | 0.60 | 0.616 | 0.19–1.89 | 7 | 1.25 | 0.348 | 0.47–3.29 | |
| 4 | 8 | 0.73 | 0.479 | 0.27–1.93 | 3 | 0.35 | 0.871 | 0.09–1.35 | |
| 5 | 7 | 1.06 | 0.099 | 0.40–2.83 | 5 | 0.72 | 0.442 | 0.24–2.16 | |
| Cerebrovascular diseases (I60-I69) | 1 (ref.) | 31 | 1.00 | 51 | 1.00 | ||||
| 2 | 34 | 1.12 | 0.34 | 0.67–1.86 | 52 | 0.93 | 0.271 | 0.62–1.39 | |
| 3 | 17 | 1.08 | 0.207 | 0.59–1.97 | 33 | 1.37 | 0.832 | 0.88–2.13 | |
| 4 | 23 | 1.25 | 0.551 | 0.70–2.25 | 32 | 0.90 | 0.322 | 0.56–1.45 | |
| 5 | 29 | 2.12 | 0.995 | 1.26–3.57 | 38 | 1.51 | 0.937 | 0.98–2.33 | |
| Disease of the respiratory system (J00-J99) | 1 (ref.) | 35 | 1.00 | 25 | 1.00 | ||||
| 2 | 43 | 1.19 | 0.532 | 0.74–1.91 | 22 | 0.94 | 0.148 | 0.52–1.73 | |
| 3 | 17 | 0.95 | 0.138 | 0.53–1.71 | 6 | 0.52 | 0.852 | 0.21–1.26 | |
| 4 | 24 | 1.10 | 0.267 | 0.63–1.94 | 17 | 1.12 | 0.251 | 0.57–2.19 | |
| 5 | 11 | 0.66 | 0.754 | 0.33–1.33 | 15 | 1.36 | 0.636 | 0.70–2.62 | |
| Acute respiratory diseases (J00-J06; J10-J18; J20-J22) | 1 (ref.) | 10 | 1.00 | 5 | 1.00 | ||||
| 2 | 15 | 1.68 | 0.768 | 0.72–3.95 | 6 | 1.11 | 0.13 | 0.33–3.74 | |
| 3 | 5 | 1.02 | 0.025 | 0.34–3.02 | nr | ||||
| 4 | 8 | 1.39 | 0.477 | 0.51–3.79 | 9 | 2.67 | 0.894 | 0.81–8.76 | |
| 5 | 4 | 0.96 | 0.059 | 0.29–3.12 | 5 | 2.10 | 0.747 | 0.59–7.52 | |
| Chronic diseases of the lower respiratory tract (except asthma) (J40-J44; J47) | 1 (ref.) | 12 | 1.00 | 11 | 1.00 | ||||
| 2 | 15 | 1.11 | 0.204 | 0.50–2.45 | 6 | 0.64 | 0.579 | 0.22–1.88 | |
| 3 | 5 | 0.79 | 0.332 | 0.28–2.29 | 3 | 0.66 | 0.754 | 0.33–1.33 | |
| 4 | 9 | 1.17 | 0.253 | 0.45–3.02 | nr | ||||
| 5 | 3 | 0.51 | 0.688 | 0.14–1.87 | nr | ||||
| Cause (ICD-10 Code) | Exposure Class | MEN | WOMEN | ||||||
|---|---|---|---|---|---|---|---|---|---|
| n | HR | 1 − p | CI95% | N | HR | 1 − p | CI95% | ||
| Natural causes (A00-R99) | 1 (ref.) | 507 | 1.00 | 529 | 1.00 | ||||
| 2 | 464 | 1.03 | 0.34 | 0.90–1.17 | 457 | 0.98 | 0.232 | 0.86–1.12 | |
| 3 | 371 | 1.09 | 0.754 | 0.94–1.25 | 380 | 1.04 | 0.415 | 0.90–1.20 | |
| Diseases of the circulatory system (I00-I99) | 1 (ref.) | 220 | 1.00 | 286 | 1.00 | ||||
| 2 | 181 | 0.94 | 0.427 | 0.77–1.16 | 234 | 0.97 | 0.281 | 0.81–1.16 | |
| 3 | 175 | 1.29 | 0.982 | 1.04–1.59 | 206 | 1.05 | 0.401 | 0.87–1.27 | |
| Heart diseases (I00-I52) | 1 (ref.) | 141 | 1.00 | 177 | 1.00 | ||||
| 2 | 119 | 0.96 | 0.247 | 0.75–1.24 | 137 | 0.92 | 0.511 | 0.73–1.16 | |
| 3 | 114 | 1.27 | 0.925 | 0.98–1.65 | 137 | 1.11 | 0.616 | 0.88–1.41 | |
| Ischemic heart diseases (IHD) (I20-I25) | 1 (ref.) | 40 | 1.00 | 44 | 1.00 | ||||
| 2 | 32 | 0.86 | 0.459 | 0.53–1.39 | 35 | 0.97 | 0.094 | 0.61–1.55 | |
| 3 | 39 | 1.50 | 0.912 | 0.94–2.40 | 35 | 0.95 | 0.163 | 0.59–1.53 | |
| Acute myocardial infarction (AMI) (I21) | 1 (ref.) | 16 | 1.00 | 17 | 1.00 | ||||
| 2 | 9 | 0.66 | 0.656 | 0.28–1.56 | 14 | 0.90 | 0.225 | 0.42–1.90 | |
| 3 | 15 | 1.11 | 0.218 | 0.52–2.36 | 8 | 0.56 | 0.799 | 0.23–1.36 | |
| Cerebrovascular diseases (I60-I69) | 1 (ref.) | 47 | 1.00 | 74 | 1.00 | ||||
| 2 | 41 | 1.05 | 0.161 | 0.68–1.62 | 73 | 1.16 | 0.626 | 0.83–1.63 | |
| 3 | 46 | 1.63 | 0.975 | 1.06–2.51 | 59 | 1.14 | 0.525 | 0.80–1.63 | |
| Trend | 1.91 | 0.886 | 0.86–4.26 | 1.32 | 0.547 | 0.64–2.71 | |||
| Disease of the respiratory system (J00-J99) | 1 (ref.) | 49 | 1.00 | 32 | 1.00 | ||||
| 2 | 55 | 1.29 | 0.789 | 0.86–1.94 | 27 | 1.02 | 0.06 | 0.60–1.73 | |
| 3 | 26 | 0.79 | 0.657 | 0.48–1.29 | 26 | 1.37 | 0.739 | 0.79–2.36 | |
| Acute respiratory diseases (J00-J06; J10-J18; J20-J22) | 1 (ref.) | 16 | 1.00 | 7 | 1.00 | ||||
| 2 | 17 | 1.24 | 0.448 | 0.61–2.52 | 8 | 1.46 | 0.522 | 0.52–4.10 | |
| 3 | 9 | 0.99 | 0.014 | 0.42–2.34 | 11 | 2.46 | 0.924 | 0.91–6.66 | |
| Chronic diseases of the lower respiratory tract (except asthma) (J40-J44; J47) | 1 (ref.) | 16 | 1.00 | 13 | 1.00 | ||||
| 2 | 17 | 1.22 | 0.416 | 0.60–2.51 | 7 | 0.66 | 0.598 | 0.26–1.73 | |
| 3 | 11 | 0.91 | 0.174 | 0.41–2.03 | 3 | 0.38 | 0.859 | 0.10–1.38 | |
| Cause (ICD-10 Code) | Exposure Class | MEN | WOMEN | ||||||
|---|---|---|---|---|---|---|---|---|---|
| n | HR | 1 − p | CI95% | N | HR | 1 − p | CI95% | ||
| Natural causes (A00-R99) | 1 (ref.) | 369 | 1.00 | 403 | 1.00 | ||||
| 2 | 337 | 1.07 | 0.66 | 0.93–1.25 | 329 | 0.95 | 0.491 | 0.82–1.1 | |
| 3 | 451 | 1.07 | 0.646 | 0.93–1.23 | 422 | 0.98 | 0.236 | 0.85–1.12 | |
| 4 | 185 | 1.19 | 0.948 | 1–1.42 | 212 | 1.19 | 0.957 | 1.01–1.4 | |
| Diseases of the circulatory system (I00-I99) | 1 (ref.) | 159 | 1.00 | 220 | 1.00 | ||||
| 2 | 137 | 1.04 | 0.249 | 0.83–1.3 | 158 | 0.86 | 0.845 | 0.7–1.06 | |
| 3 | 178 | 1.01 | 0.107 | 0.82–1.26 | 229 | 1.03 | 0.212 | 0.85–1.23 | |
| 4 | 102 | 1.54 | 0.999 | 1.2–1.97 | 119 | 1.21 | 0.911 | 0.97–1.52 | |
| Heart diseases (I00-I52) | 1 (ref.) | 98 | 1.00 | 133 | 1.00 | ||||
| 2 | 88 | 1.07 | 0.371 | 0.8–1.43 | 100 | 0.90 | 0.592 | 0.69–1.16 | |
| 3 | 122 | 1.12 | 0.583 | 0.86–1.46 | 141 | 1.03 | 0.211 | 0.81–1.31 | |
| 4 | 66 | 1.61 | 0.997 | 1.18–2.2 | 77 | 1.30 | 0.93 | 0.98–1.72 | |
| Ischemic heart diseases (IHD) (I20-I25) | 1 (ref.) | 30 | 1.00 | 31 | 1.00 | ||||
| 2 | 25 | 0.97 | 0.085 | 0.57–1.65 | 26 | 0.98 | 0.054 | 0.58–1.65 | |
| 3 | 36 | 1.03 | 0.11 | 0.64–1.68 | 39 | 1.18 | 0.501 | 0.73–1.89 | |
| 4 | 20 | 1.58 | 0.886 | 0.9–2.78 | 18 | 1.31 | 0.642 | 0.73–2.35 | |
| Acute myocardial infarction (AMI) (I21) | 1 (ref.) | 13 | 1.00 | 12 | 1.00 | ||||
| 2 | 8 | 0.69 | 0.594 | 0.28–1.66 | 12 | 1.14 | 0.251 | 0.51–2.54 | |
| 3 | 12 | 0.75 | 0.529 | 0.34–1.64 | 10 | 0.73 | 0.539 | 0.31–1.69 | |
| 4 | 7 | 1.27 | 0.389 | 0.51–3.18 | 5 | 0.97 | 0.047 | 0.34–2.75 | |
| Cerebrovascular diseases (I60-I69) | 1 (ref.) | 34 | 1.00 | 55 | 1.00 | ||||
| 2 | 31 | 1.11 | 0.321 | 0.68–1.8 | 48 | 1.06 | 0.216 | 0.72–1.56 | |
| 3 | 40 | 1.08 | 0.256 | 0.68–1.71 | 65 | 1.18 | 0.629 | 0.82–1.69 | |
| 4 | 29 | 2.06 | 0.996 | 1.25–3.38 | 38 | 1.55 | 0.963 | 1.03–2.35 | |
| Disease of the respiratory system (J00-J99) | 1 (ref.) | 39 | 1.00 | 27 | 1.00 | ||||
| 2 | 39 | 1.22 | 0.61 | 0.78–1.9 | 20 | 0.87 | 0.357 | 0.49–1.56 | |
| 3 | 41 | 0.97 | 0.124 | 0.62–1.5 | 23 | 0.81 | 0.545 | 0.46–1.41 | |
| 4 | 11 | 0.67 | 0.752 | 0.35–1.32 | 15 | 1.25 | 0.515 | 0.67–2.35 | |
| Acute respiratory diseases (J00-J06; J10-J18; J20-J22) | 1 (ref.) | 12 | 1.00 | 5 | 1.00 | ||||
| 2 | 13 | 1.29 | 0.48 | 0.59–2.84 | 6 | 1.48 | 0.481 | 0.45–4.84 | |
| 3 | 13 | 0.97 | 0.059 | 0.44–2.13 | 10 | 2.10 | 0.825 | 0.72–6.16 | |
| 4 | 4 | 0.78 | 0.333 | 0.25–2.42 | 5 | 2.26 | 0.802 | 0.65–7.8 | |
| Chronic diseases of the lower respiratory tract (except asthma) (J40-J44; J47) | 1 (ref.) | 12 | 1.00 | 11 | 1.00 | ||||
| 2 | 15 | 1.56 | 0.75 | 0.73–3.34 | 6 | 0.64 | 0.622 | 0.24–1.73 | |
| 3 | 14 | 1.12 | 0.225 | 0.52–2.43 | 5 | 0.43 | 0.88 | 0.15–1.25 | |
| 4 | 3 | 0.61 | 0.559 | 0.17–2.15 | n.r. | ||||
References
- Nilimaa, J. Smart Materials and Technologies for Sustainable Concrete Construction. Dev. Built Environ. 2023, 15, 100177. [Google Scholar] [CrossRef]
- Su, N.; Lou, L.; Amirkhanian, A.; Amirkhanian, S.N.; Xiao, F. Assessment of Effective Patching Material for Concrete Bridge Deck—A Review. Constr. Build. Mater. 2021, 293, 123520. [Google Scholar] [CrossRef]
- Gagg, C.R. Cement and Concrete as an Engineering Material: An Historic Appraisal and Case Study Analysis. Eng. Fail. Anal. 2014, 40, 114–140. [Google Scholar] [CrossRef]
- Chung, D.D.L. Use of Polymers for Cement-Based Structural Materials. J. Mater. Sci. 2004, 39, 2973–2978. [Google Scholar] [CrossRef]
- Cazacu, C.; Dumitriu, C.; Barbulescu, A. Concrete CFRP-Reinforced Beam Performances, Tests and Simulations. Sustainability 2024, 16, 2614. [Google Scholar] [CrossRef]
- Hosen, K. Assessment and Rehabilitation of Seismically Vulnerable Industrial RCC Structures. Comput. Eng. Phys. Model. 2024, 7, 30–48. [Google Scholar] [CrossRef]
- Hosen, K. Seismic Vulnerability and Rehabilitation Strategies for Industrial RC Structures. Civ. Environ. Eng. Rep. 2024, 34, 328–343. [Google Scholar] [CrossRef]
- Mechtcherine, V. Novel Cement-Based Composites for the Strengthening and Repair of Concrete Structures. Constr. Build. Mater. 2013, 41, 365–373. [Google Scholar] [CrossRef]
- Bărbulescu, A.; Hosen, K. Cement Industry Pollution and Its Impact on the Environment and Population Health: A Review. Toxics 2025, 13, 587. [Google Scholar] [CrossRef] [PubMed]
- Chen, J.; Hu, L.; Sun, C.; Fan, Y.; Zhou, X.; He, Y.; Su, X.; Wang, Y.; Hou, L.; Ma, W. Examination of Spatial and Temporal Evolution Characteristics of Carbon Emission and Influencing Factors in Territorial Spatial Func-tional Areas: A Case Study of Mountainous City-Chongqing. Integr. Environ. Assess. Manag. 2025, 21, 360–373. [Google Scholar] [CrossRef] [PubMed]
- Li, R.; Wei, Y.; Cai, W.G.; Liu, Y.; You, K.; Yu, Y. Tracking Cement Transportation Carbon Emissions in China: Historical Assessment and Future Simulation. Environ. Impact Assess. Rev. 2024, 109, 107636. [Google Scholar] [CrossRef]
- Zou, L.; Ni, Y.; Gao, Y.; Tang, F.; Jin, J.; Chen, J. Spatial Variation of PCDD/F and PCB Emissions and Their Composition Profiles in Stack Flue Gas from the Typical Cement Plants in China. Chemosphere 2018, 195, 491–497. [Google Scholar] [CrossRef]
- Leone, V.; Cervone, G.; Iovino, P. Impact Assessment of PM10 Cement Plants Emissions on Urban Air Quality Using the SCIPUFF Dispersion Model. Environ. Monit. Assess. 2016, 188, 499. [Google Scholar] [CrossRef]
- Mosca, S.; Benedetti, P.; Guerriero, E.; Rotatori, M. Assessment of Nitrous Oxide Emission from Cement Plants: Real Data Measured with Both Fourier Transform Infrared and Nondispersive Infrared Techniques. J. Air Waste Manag. Assoc. 2014, 64, 1270–1278. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Chinyama, M.P.M. Alternative Fuels in Cement Manufacturing. In Alternative Fuel; IntechOpen: London, UK, 2011; ISBN 978-953-307-372-9. [Google Scholar]
- Cetintepe, S.P.; Demirbas, O.B.; Dinke, B.; Ilhan, M.N. Is Exposure to Cement Dust and Heavy Metals Associated with Reduced Pulmonary Function? A Cross-Sectional Study among Cement Factory Workers in Türkiye. BMJ Open 2025, 15, e102214. [Google Scholar] [CrossRef] [PubMed]
- Mkulisi, A.; Rathebe, P.C.; Kachingwe, E.; Bidassey-Manilal, S. Prevalence of Chronic Respiratory Symptoms among Cement Factory Workers in Gauteng Province, South Africa. J. Occup. Environ. Hyg. 2024, 21, 202–211. [Google Scholar] [CrossRef]
- Dewangan, P.K.; Verma, N.; Shrivastava, N.; Prasad, M.A. Pulmonary Function Parameters and Its Determinants among Cement Factory Workers in Chhattisgarh: A Cross-Sectional Study. Indian J. Public Health 2021, 65, 226–230. [Google Scholar] [CrossRef] [PubMed]
- Shanshal, S.A.; Al-Qazaz, H.K. Consequences of Cement Dust Exposure on Pulmonary Function in Cement Factory Workers. Am. J. Ind. Med. 2021, 64, 192–197. [Google Scholar] [CrossRef]
- Shanshal, S.A.; Al-Qazaz, H.K. Spirometric Outcomes and Oxidative Stress Among Cement Factory Workers: Results from a Cross-Sectional Study. J. Occup. Environ. Med. 2020, 62, e581–e585. [Google Scholar] [CrossRef] [PubMed]
- De Souza Zorzenão, P.C.; Santos Silva, J.C.D.; Moreira, C.A.B.; Milla Pinto, V.; de Souza Tadano, Y.; Yamamoto, C.I.; Godoi, R.H.M. Impacts of PM2.5 Exposure near Cement Facilities on Human Health and Years of Life Lost: A Case Study in Brazil. J. Environ. Manag. 2024, 370, 122975. [Google Scholar] [CrossRef]
- Mallongi, A.; Ernyasih, E. Health Risk Assessments of Exposure Carbon Dioxide among Communities and Children around Tonasa Cement Plant, Pangkep Regency, Indonesia. Monte Carlo Simulation (MCS) Application. Braz. J. Biol. 2023, 83, e271436. [Google Scholar] [CrossRef]
- Han, J.; Xu, C.; Jin, J.; Hu, J. PCNs, PCBs, and PCDD/Fs in Soil around a Cement Kiln Co-Processing Municipal Wastes in Northwestern China: Levels, Distribution, and Potential Human Health Risks. Int. J. Environ. Res. Public Health 2022, 19, 12860. [Google Scholar] [CrossRef]
- Kim, J.; Kim, B.; Bak, S.H.; Oh, Y.-M.; Kim, W.J. A Comparative Study of Chest CT Findings Regarding the Effects of Regional Dust Exposure on Patients with COPD Living in Urban Areas and Rural Areas near Cement Plants. Respir. Res. 2021, 22, 43. [Google Scholar] [CrossRef]
- Ferroni, E.; Cestari, L.; Cinquetti, S.; Corti, M.C.; Fedeli, U.; Donato, F. Residential cohort study to assess the impact of emissions released by a cement plant on the health status of the population residing in Pederobba (Veneto Region, Northern Italy). Epidemiol. Prev. 2021, 45, 82–91. [Google Scholar] [CrossRef]
- Raffetti, E.; Treccani, M.; Donato, F. Cement Plant Emissions and Health Effects in the General Population: A Systematic Review. Chemosphere 2019, 218, 211–222. [Google Scholar] [CrossRef] [PubMed]
- Bertoldi, M.; Borgini, A.; Tittarelli, A.; Fattore, E.; Cau, A.; Fanelli, R.; Crosignani, P. Health Effects for the Population Living near a Cement Plant: An Epidemiological Assessment. Environ. Int. 2012, 41, 1–7. [Google Scholar] [CrossRef] [PubMed]
- Giordano, F.; Grippo, F.; Perretta, V.; Figà-Talamanca, I. Impact of Cement Production Emissions on Health: Effects on the Mortality Patterns of the Population Living in the Vicinity of a Cement Plant. Fresenius Environ. Bull. 2012, 21, 1905–1909. [Google Scholar]
- ISPRA Working Group. La Qualità Dell’aria in Molise—Report 2022; ISPRA: Lombardy, Italy, 2023; p. 65. [Google Scholar]
- Bustaffa, E.; Mangia, C.; Cori, L.; Bianchi, F.; Cervino, M.; Minichilli, F. Cardiorespiratory Diseases in an Industrialized Area: A Retrospective Population-Based Cohort Study. BMC Public Health 2023, 23, 2031. [Google Scholar] [CrossRef] [PubMed]
- Scire, J.; Robe, F.; Fernau, M.; Yamartino, R. A User’s Guide for the CALMET Meteorological Model (Version 5); U.S. Environmental Protection Agency: Washington, DC, USA, 1998. [Google Scholar]
- Scire, J.S.; Strimaitis, D.G.; Yamartino, R.J. A User’s Guide for the CALPUFF Meteorological Model (Version 5); Earth Tech Inc.: Land O’ Lakes, FL, USA, 2000. [Google Scholar]
- Rzeszutek, M. Parameterization and Evaluation of the CALMET/CALPUFF Model System in near-Field and Complex Terrain—Terrain Data, Grid Resolution and Terrain Adjustment Method. Sci. Total Environ. 2019, 689, 31–46. [Google Scholar] [CrossRef]
- Mangia, C.; Bustaffa, E.; Cervino, M.; Bianchi, F.; Cori, L.; Minichilli, F. Application of Complementary Air Quality Exposure Assessment Methods in a Complex Industrial-Urban Environment: A Case Study from Venafro Valley, Italy. Air Qual. Atmos. Health 2026, 19, 10. [Google Scholar] [CrossRef]
- Caranci, N.; Biggeri, A.; Grisotto, L.; Pacelli, B.; Spadea, T.; Costa, G. L’indice di deprivazione italiano a livello di sezione di censimento: Definizione, descrizione e associazione con la mortalità [The Italian deprivation index at census block level: Definition, description and association with general mortality]. Epidemiol. Prev. 2010, 34, 167–176. [Google Scholar]
- Rosano, A.; Pacelli, B.; Zengarini, N.; Costa, G.; Cislaghi, C.; Caranci, N. Update and review of the 2011 Italian deprivation index calculated at the census section level [Aggiornamento e revisione dell’indice di deprivazione italiano 2011 a livello di sezione di censimento]. Epidemiol. Prev. 2020, 44, 162–170. [Google Scholar] [CrossRef]
- Biggeri, A.; Stoppa, G.; Catelan, D. P-value and the probability of direction of effect. Epidemiol. Prev. 2022, 46, 204–210. [Google Scholar] [CrossRef] [PubMed]
- Wasserstein, R.L.; Schirm, A.L.; Lazar, N.A. Moving to a World Beyond “p < 0.05”. Am. Stat. 2019, 73, 1–19. [Google Scholar] [CrossRef]
- Bustaffa, E.; Curzio, O.; Donzelli, G.; Gorini, F.; Linzalone, N.; Redini, M.; Bianchi, F.; Minichilli, F. Risk Associations between Vehicular Traffic Noise Exposure and Cardiovascular Diseases: A Residential Retrospective Cohort Study. Int. J. Environ. Res. Public Health 2022, 19, 10034. [Google Scholar] [CrossRef]
- Ancona, C.; Badaloni, C.; Mataloni, F.; Bolignano, A.; Bucci, S.; Cesaroni, G.; Sozzi, R.; Davoli, M.; Forastiere, F. Mortality and Morbidity in a Population Exposed to Multiple Sources of Air Pollution: A Retrospective Cohort Study Using Air Dispersion Models. Environ. Res. 2015, 137, 467–474. [Google Scholar] [CrossRef]
- Ranzi, A.; Fano, V.; Erspamer, L.; Lauriola, P.; Perucci, C.A.; Forastiere, F. Mortality and Morbidity among People Living Close to Incinerators: A Cohort Study Based on Dispersion Modeling for Exposure Assessment. Environ. Health 2011, 10, 22. [Google Scholar] [CrossRef] [PubMed]
- Negri, E.; Bravi, F.; Catalani, S.; Guercio, V.; Metruccio, F.; Moretto, A.; La Vecchia, C.; Apostoli, P. Health Effects of Living near an Incinerator: A Systematic Review of Epidemiological Studies, with Focus on Last Generation Plants. Environ. Res. 2020, 184, 109305. [Google Scholar] [CrossRef]
- de Titto, E.; Savino, A. Environmental and Health Risks Related to Waste Incineration. Waste Manag. Res. 2019, 37, 976–986. [Google Scholar] [CrossRef] [PubMed]


| CALMET | |
|---|---|
| Horizontal domain | 61 km × 61 km |
| Grid size | 1 km × 1 km |
| Number grid points Nx, Ny | 61, 61 |
| Number of vertical levels | 10 |
| First vertical level | 20 m |
| Vertical domain | 4000 m |
| Cause of Death | ICD-10 Codes |
|---|---|
| Natural causes | A00-R99 |
| Diseases of the circulatory system | I00-I99 |
| Heart diseases | I00-I52 |
| Ischemic heart diseases | I20-I25 |
| Acute myocardial infarction | I21 |
| Cerebrovascular diseases | I60-I69 |
| Diseases of the respiratory system | J00-J99 |
| Acute respiratory diseases | J00-J06, J10-J18, J20-J22 |
| Chronic diseases of the lower respiratory tract (except asthma) | J40-J44, J47 |
| Cohort (n = 29,495) | PY | Circulatory System | Respiratory System | |||||
|---|---|---|---|---|---|---|---|---|
| Deaths | Crude Rate x 1000 PY | 95%CI | Deaths | Crude Rate x 1000 PY | 95%CI | |||
| (CS) | (RS) | |||||||
| Total | 317,810 | 1302 | 215 | |||||
| Sex | Men | 156,030 | 576 | 3.69 | 3.40–4.01 | 130 | 0.83 | 0.70–0.99 |
| Women | 161,780 | 726 | 4.49 | 4.17–4.83 | 85 | 0.53 | 0.42–0.65 | |
| Age classes (years) | 0–44 | 138,462 | 15 | 0.11 | 0.07–0.18 | 4 | 0.03 | 0.01–0.08 |
| 45–54 | 45,893 | 28 | 0.61 | 0.42–0.88 | 0 | -- | -- | |
| 55–64 | 45,222 | 51 | 1.13 | 0.86–1.48 | 8 | 0.18 | 0.09–0.35 | |
| 65–74 | 38,579 | 130 | 3.37 | 2.84–4.11 | 25 | 0.65 | 0.44–0.96 | |
| 75–84 | 29,899 | 441 | 14.75 | 13.55–16.32 | 87 | 2.91 | 2.36–3.59 | |
| 85+ | 19,755 | 637 | 32.25 | 30.43–35.68 | 91 | 4.61 | 3.75–5.66 | |
| Socioeconomic deprivation classes (DI) | Low | 80,249 | 280 | 3.48 | 3.10–3.91 | 46 | 0.57 | 0.43–0.76 |
| Medium-low | 111,424 | 447 | 4.01 | 3.66–4.40 | 77 | 0.69 | 0.55–0.86 | |
| Medium | 34,939 | 162 | 4.64 | 3.97–5.41 | 21 | 0.6 | 0.39–0.92 | |
| Medium-high | 53,623 | 234 | 4.36 | 3.84–4.96 | 38 | 0.71 | 0.52–0.97 | |
| High | 37,395 | 179 | 4.79 | 4.13–5.54 | 33 | 0.89 | 0.63–1.25 | |
| NOx exposure classes (µg/m3) | Class 1 *: 0.07–0.19 | 83,608 | 379 | 4.53 | 4.09–5.01 | 66 | 0.79 | 0.62–1.01 |
| Class 2: 0.20–0.29 | 81,713 | 295 | 3.61 | 3.22–4.05 | 59 | 0.72 | 0.56–0.93 | |
| Class 3: 0.30–0.37 | 116,986 | 407 | 3.48 | 3.16–3.83 | 64 | 0.55 | 0.43–0.70 | |
| Class 4: 0.38–1.92 | 35,503 | 221 | 6.22 | 5.46–7.10 | 26 | 0.73 | 0.50–1.08 | |
| Proximity to selected roads | No | 69,809 | 244 | 3.5 | 3.08–3.96 | 39 | 0.56 | 0.41–0.76 |
| Yes | 248,004 | 1058 | 4.27 | 4.02–4.53 | 176 | 0.71 | 0.61–0.82 | |
| Cause (ICD-10 Code) | Exposure Class | MEN | WOMEN | ||||||
|---|---|---|---|---|---|---|---|---|---|
| n | HR | 1 − p | CI95% | N | HR | 1 − p | CI95% | ||
| Natural causes (A00-R99) | 1 (ref.) | 369 | 403 | ||||||
| 2 | 337 | 1.07 | 0.62 | 0.92–1.25 | 329 | 0.96 | 0.370 | 0.83–1.12 | |
| 3 | 451 | 1.10 | 0.74 | 0.94–1.27 | 422 | 0.98 | 0.172 | 0.85–1.14 | |
| 4 | 185 | 1.19 | 0.951 | 1.00–1.41 | 212 | 1.19 | 0.956 | 1.00–1.42 | |
| Diseases of the circulatory system (I00-I99) | 1 (ref.) | 159 | 220 | ||||||
| 2 | 137 | 1.03 | 0.221 | 0.81–1.31 | 158 | 0.87 | 0.800 | 0.70–1.08 | |
| 3 | 178 | 1.05 | 0.326 | 0.84–1.31 | 229 | 1.01 | 0.118 | 0.84–1.23 | |
| 4 | 102 | 1.60 | 0.999 | 1.24–2.06 | 119 | 1.17 | 0.823 | 0.93–1.48 | |
| Heart diseases (I00-I52) | 1 (ref.) | 98 | 133 | ||||||
| 2 | 88 | 1.06 | 0.315 | 0.79–1.44 | 100 | 0.96 | 0.208 | 0.73–1.27 | |
| 3 | 122 | 1.13 | 0.596 | 0.85–1.49 | 141 | 1.00 | 0.030 | 0.78–1.29 | |
| 4 | 66 | 1.66 | 0.998 | 1.21–2.29 | 77 | 1.24 | 0.855 | 0.93–1.67 | |
| Ischemic heart diseases (IHD) (I20-I25) | 1 (ref.) | 30 | 31 | ||||||
| 2 | 25 | 0.94 | 0.158 | 0.54–1.65 | 26 | 1.03 | 0.083 | 0.60–1.78 | |
| 3 | 36 | 1.05 | 0.138 | 0.63–1.74 | 39 | 1.17 | 0.457 | 0.71–1.92 | |
| 4 | 20 | 1.61 | 0.889 | 0.90–2.89 | 18 | 1.01 | 0.031 | 0.55–1.86 | |
| Acute myocardial infarction (AMI) (I21) | 1 (ref.) | 13 | 12 | ||||||
| 2 | 8 | 0.67 | 0.600 | 0.27–1.69 | 12 | 1.01 | 0.024 | 0.44–2.35 | |
| 3 | 12 | 0.68 | 0.639 | 0.29–1.56 | 10 | 0.76 | 0.465 | 0.31–1.83 | |
| 4 | 7 | 1.07 | 0.107 | 0.41–2.81 | 5 | 0.74 | 0.418 | 0.25–2.18 | |
| Cerebrovascular diseases (I60-I69) | 1 (ref.) | 34 | 55 | ||||||
| 2 | 31 | 1.13 | 0.362 | 0.68–1.88 | 48 | 0.96 | 0.159 | 0.64–1.44 | |
| 3 | 40 | 1.16 | 0.466 | 0.72–1.88 | 65 | 1.13 | 0.489 | 0.78–1.65 | |
| 4 | 29 | 2.11 | 0.996 | 1.27–3.53 | 38 | 1.52 | 0.946 | 0.99–2.34 | |
| Disease of the respiratory system (J00-J99) | 1 (ref.) | 39 | 27 | ||||||
| 2 | 39 | 1.19 | 0.524 | 0.74–1.90 | 20 | 0.98 | 0.040 | 0.53–1.81 | |
| 3 | 41 | 1.01 | 0.046 | 0.64–1.61 | 23 | 0.85 | 0.414 | 0.48–1.52 | |
| 4 | 11 | 0.66 | 0.772 | 0.33–1.30 | 15 | 1.39 | 0.681 | 0.73–2.68 | |
| Acute respiratory diseases (J00-J06; J10-J18; J20-J22) | 1 (ref.) | 12 | 5 | ||||||
| 2 | 13 | 1.58 | 0.714 | 0.68–3.65 | 6 | 1.33 | 0.353 | 0.39–4.51 | |
| 3 | 13 | 1.11 | 0.200 | 0.49–2.52 | 10 | 1.83 | 0.713 | 0.60–5.58 | |
| 4 | 4 | 0.90 | 0.143 | 0.28–2.86 | 5 | 2.33 | 0.803 | 0.64–8.44 | |
| Chronic diseases of the lower respiratory tract (except asthma) (J40-J44; J47) | 1 (ref.) | 12 | 11 | ||||||
| 2 | 15 | 1.26 | 0.431 | 0.57–2.78 | 6 | 0.79 | 0.326 | 0.27–2.32 | |
| 3 | 14 | 1.05 | 0.093 | 0.46–2.38 | 5 | 0.49 | 0.785 | 0.16–1.51 | |
| 4 | nr | nr | |||||||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Bustaffa, E.; Mangia, C.; Cori, L.; Bianchi, F.; Cervino, M.; Imiotti, M.C.; Minichilli, F. Risk of Cardiorespiratory Mortality Associated with Emissions from a Cement Plant: A Residential Cohort Study. Environments 2026, 13, 153. https://doi.org/10.3390/environments13030153
Bustaffa E, Mangia C, Cori L, Bianchi F, Cervino M, Imiotti MC, Minichilli F. Risk of Cardiorespiratory Mortality Associated with Emissions from a Cement Plant: A Residential Cohort Study. Environments. 2026; 13(3):153. https://doi.org/10.3390/environments13030153
Chicago/Turabian StyleBustaffa, Elisa, Cristina Mangia, Liliana Cori, Fabrizio Bianchi, Marco Cervino, Maria Cristina Imiotti, and Fabrizio Minichilli. 2026. "Risk of Cardiorespiratory Mortality Associated with Emissions from a Cement Plant: A Residential Cohort Study" Environments 13, no. 3: 153. https://doi.org/10.3390/environments13030153
APA StyleBustaffa, E., Mangia, C., Cori, L., Bianchi, F., Cervino, M., Imiotti, M. C., & Minichilli, F. (2026). Risk of Cardiorespiratory Mortality Associated with Emissions from a Cement Plant: A Residential Cohort Study. Environments, 13(3), 153. https://doi.org/10.3390/environments13030153

